137 related articles for article (PubMed ID: 7909336)
1. A new arylpiperazine antipsychotic with high D2/D3/5-HT1A/alpha 1A-adrenergic affinity and a low potential for extrapyramidal effects.
Reitz AB; Bennett DJ; Blum PS; Codd EE; Maryanoff CA; Ortegon ME; Renzi MJ; Scott MK; Shank RP; Vaught JL
J Med Chem; 1994 Apr; 37(8):1060-2. PubMed ID: 7909336
[No Abstract] [Full Text] [Related]
2. 2-aminotetralin-derived substituted benzamides with mixed dopamine D2, D3, and serotonin 5-HT1A receptor binding properties: a novel class of potential atypical antipsychotic agents.
Homan EJ; Copinga S; Elfström L; van der Veen T; Hallema JP; Mohell N; Unelius L; Johansson R; Wikström HV; Grol CJ
Bioorg Med Chem; 1998 Nov; 6(11):2111-26. PubMed ID: 9881101
[TBL] [Abstract][Full Text] [Related]
3. Orally active benzamide antipsychotic agents with affinity for dopamine D2, serotonin 5-HT1A, and adrenergic alpha1 receptors.
Reitz AB; Baxter EW; Codd EE; Davis CB; Jordan AD; Maryanoff BE; Maryanoff CA; McDonnell ME; Powell ET; Renzi MJ; Schott MR; Scott MK; Shank RP; Vaught JL
J Med Chem; 1998 Jun; 41(12):1997-2009. PubMed ID: 9622541
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT.
Homan EJ; Copinga S; Unelius L; Jackson DM; Wikström HV; Grol CJ
Bioorg Med Chem; 1999 Jul; 7(7):1263-71. PubMed ID: 10465402
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of heterocyclic carboxamides as potential antipsychotic agents.
Norman MH; Navas F; Thompson JB; Rigdon GC
J Med Chem; 1996 Nov; 39(24):4692-703. PubMed ID: 8941382
[TBL] [Abstract][Full Text] [Related]
6. Aminopyrimidines with high affinity for both serotonin and dopamine receptors.
Wustrow D; Belliotti T; Glase S; Kesten SR; Johnson D; Colbry N; Rubin R; Blackburn A; Akunne H; Corbin A; Davis MD; Georgic L; Whetzel S; Zoski K; Heffner T; Pugsley T; Wise L
J Med Chem; 1998 Feb; 41(5):760-71. PubMed ID: 9513604
[TBL] [Abstract][Full Text] [Related]
7. N-aryl-N'-benzylpiperazines as potential antipsychotic agents.
Reitz AB; Baxter EW; Bennett DJ; Codd EE; Jordan AD; Malloy EA; Maryanoff BE; McDonnell ME; Ortegon ME; Renzi MJ
J Med Chem; 1995 Oct; 38(21):4211-22. PubMed ID: 7473548
[TBL] [Abstract][Full Text] [Related]
8. Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors.
Malmberg A; Jackson DM; Eriksson A; Mohell N
Mol Pharmacol; 1993 May; 43(5):749-54. PubMed ID: 8099194
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of a series of substituted N-alkoxyimides and -amides as potential atypical antipsychotic agents.
Hrib NJ; Jurcak JG; Huger FP; Errico CL; Dunn RW
J Med Chem; 1991 Mar; 34(3):1068-72. PubMed ID: 1672156
[TBL] [Abstract][Full Text] [Related]
10. Novel benzothiazolin-2-one and benzoxazin-3-one arylpiperazine derivatives with mixed 5HT1A/D2 affinity as potential atypical antipsychotics.
Taverne T; Diouf O; Depreux P; Poupaert JH; Lesieur D; Guardiola-Lemaître B; Renard P; Rettori MC; Caignard DH; Pfeiffer B
J Med Chem; 1998 Jun; 41(12):2010-8. PubMed ID: 9622542
[TBL] [Abstract][Full Text] [Related]
11. (S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist.
TenBrink RE; Bergh CL; Duncan JN; Harris DW; Huff RM; Lahti RA; Lawson CF; Lutzke BS; Martin IJ; Rees SA; Schlachter SK; Sih JC; Smith MW
J Med Chem; 1996 Jun; 39(13):2435-7. PubMed ID: 8691438
[No Abstract] [Full Text] [Related]
12. Binding characteristics of remoxipride and its metabolites to dopamine D2 and D3 receptors.
Mohell N; Sällemark M; Rosqvist S; Malmberg A; Högberg T; Jackson DM
Eur J Pharmacol; 1993 Jul; 238(1):121-5. PubMed ID: 8405075
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of a series of substituted benzamides: potent D2/5-HT2 antagonists and 5-HT1a agonists as neuroleptic agents.
Norman MH; Rigdon GC; Hall WR; Navas F
J Med Chem; 1996 Mar; 39(5):1172-88. PubMed ID: 8676355
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of a new model of arylpiperazines. 1. 2-[[4-(o-methoxyphenyl)piperazin-1-yl]methyl]-1, 3-dioxoperhydroimidazo[1,5-alpha]pyridine: a selective 5-HT1A receptor agonist.
López-Rodríguez ML; Rosado ML; Benhamú B; Morcillo MJ; Sanz AM; Orensanz L; Beneitez ME; Fuentes JA; Manzanares J
J Med Chem; 1996 Oct; 39(22):4439-50. PubMed ID: 8893838
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro pharmacological evaluation of novel 2-hydroxypropyl-4-arylpiperazine derivatives as serotoninergic ligands.
Fiorino F; Magli E; Severino B; Corvino A; Ciano A; Perissutti E; Frecentese F; Massarelli P; Nencini C; Santagada V; Caliendo G
Arch Pharm (Weinheim); 2014 Oct; 347(10):698-706. PubMed ID: 25113046
[TBL] [Abstract][Full Text] [Related]
16. New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluation.
Liao Y; Venhuis BJ; Rodenhuis N; Timmerman W; Wikström H; Meier E; Bartoszyk GD; Böttcher H; Seyfried CA; Sundell S
J Med Chem; 1999 Jun; 42(12):2235-44. PubMed ID: 10377229
[TBL] [Abstract][Full Text] [Related]
17. Ziprasidone: a novel antipsychotic agent with a unique human receptor binding profile.
Schmidt AW; Lebel LA; Howard HR; Zorn SH
Eur J Pharmacol; 2001 Aug; 425(3):197-201. PubMed ID: 11513838
[TBL] [Abstract][Full Text] [Related]
18. Serotonin 5-HT2 receptor, dopamine D2 receptor, and alpha 1 adrenoceptor antagonists. Conformationally flexible analogues of the atypical antipsychotic sertindole.
Andersen K; Liljefors T; Hyttel J; Perregaard J
J Med Chem; 1996 Sep; 39(19):3723-38. PubMed ID: 8809161
[TBL] [Abstract][Full Text] [Related]
19. New 1-aryl-4-(biarylmethylene)piperazines as potential atypical antipsychotics sharing dopamine D(2)-receptor and serotonin 5-HT(1A)-receptor affinities.
Feenstra RW; de Moes J; Hofma JJ; Kling H; Kuipers W; Long SK; Tulp MT; van der Heyden JA; Kruse CG
Bioorg Med Chem Lett; 2001 Sep; 11(17):2345-9. PubMed ID: 11527728
[TBL] [Abstract][Full Text] [Related]
20. 1-cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D(2)) and serotonin (5-HT(1A)) receptors.
Penjisević J; Sukalović V; Andrić D; Kostić-Rajacić S; Soskić V; Roglić G
Arch Pharm (Weinheim); 2007 Sep; 340(9):456-65. PubMed ID: 17763374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
